Gene therapy is a promising approach to curing disease, but for a number of years, the problem has been the vehicles in which we deliver the genes.

Both studies clearly show no increased risk of coronary heart disease with estrogen-alone therapy.

Both studies clearly show no increased risk of coronary heart disease with estrogen-alone therapy, and help clarify the individual assessment of risk and benefit. This new information may be reassuring to millions of women who currently take, or are appropriate candidates for, estrogen-alone therapy.

There's our No. 1 therapy for people with heart disease or for people with a moderate risk of developing heart disease. It's the only proven therapy to treat high cholesterol.

It was amazing. Therapy for six and one-half years seems to have driven a dramatic effect.

Much to our delight, it appears that this intensive therapy introduced years and years ago seems to have this long-term benefit on heart disease and stroke.